Skip to content

Effects of Remote Patient Monitoring on Heart Failure Management

Effects of Remote Patient Monitoring on Heart Failure Management: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00778986
Enrollment
100
Registered
2008-10-24
Start date
2009-03-31
Completion date
2010-09-30
Last updated
2010-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

heart failure, remote patient monitoring, telemonitoring, home monitoring, randomized controlled trial, self care

Brief summary

The purpose of this randomized controlled trial is to determine the effects of a user-centric remote patient monitoring system on heart failure management. Patients attending a Heart Failure Clinic will monitor their weight, blood pressure, ECG, and symptoms at home. The hypothesis is that the remote monitoring system will improve heart failure outcomes through increased self-care and improved clinical management.

Detailed description

Poor management of heart failure (HF) has added to the high costs and negative health outcomes from this chronic illness, including frequent hospitalization. HF patients require close monitoring to detect worsening health and to optimize their treatment. However, many patients visit their HF clinicians only once every few months, and perform minimal or no self-monitoring. Remote patient monitoring is a potential tool to help clinicians and the patients better manage HF. A remote patient monitoring system (home monitoring of vital signs and symptoms) that has been developed with extensive clinician and patient input and testing, will be studied to determine its effects on HF management. Half of one hundred patients from the University Health Network Heart Failure Clinic will be randomly placed into the remote monitoring (RM) group and the other half will be in the control group. Patients in the RM group will monitor their weight, blood pressure, ECG, and symptoms at home for 6 months. This information will be automatically sent from the medical devices wirelessly through Bluetooth to a mobile phone, which will send the information to the data servers. Both clinicians and patients will have access to the data. Patients will get automated reminder telephone calls if they do not take the number of measurements prescribed by their doctors.

Interventions

DEVICEheart failure remote patient monitoring system

remote monitoring of weight, blood pressure, ECG, and symptoms

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Heart Failure (NYHA Class II-IV) * Out-patients attending the University Health Network Heart Failure Clinic * English-speaking and able to read English * 18 years old or over

Exclusion criteria

* Awaiting heart transplantation * Not expected to survive over a year (as determined by their cardiologist) * Unable to read text on a mobile phone due to vision disability * Unable to self-care due to anxiety, depression, or decreased cognitive function * Lack of manual dexterity to accurately press buttons on the mobile phone

Design outcomes

Primary

MeasureTime frame
Self-care practices measured through Self-Care of Heart Failure Index scores and interviewsbaseline, 6 months
Brain Natriuretic Peptide valuesBaseline, 6 months
Health related quality of life measured through the Minnesota Living with Heart Failure Questionnaire scores and interviewsbaseline, 6 months

Secondary

MeasureTime frame
Number of hospitalizations and days in hospital6 months comparison between intervention and control groups
Number of Heart Failure Clinic visits6 month comparison between intervention and control groups
Number of Emergency Department visits6 month comparison between intervention and control groups
All cause mortality6 month comparison between intervention and control groups

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026